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ABSTRACT 
 
 
Inactivating mutations of the B1 proton pump subunit (ATP6V1B1) expressed in intercalated 
cells (ICs) lead to type I distal renal tubular acidosis (dRTA), a disease often associated with a 
salt and potassium losing nephropathy. Here we show that mice with disruption of the B1 
proton pump subunit gene, despite the absence of overt acidemia, display a renal loss of NaCl, 
K+ and water causing hypovolemia, hypokalemia and polyuria. We demonstrate that NaCl 
loss originates from the cortical collecting duct (CD) where activities of both ENaC in 
principals cells (PCs) and pendrin in β-ICs were impaired. In contrast, ENaC was 
appropriately up-regulated in medullary CD, suggesting that a local factor inhibits ENaC in 
the cortex. Accordingly, we detected high urinary PGE2 and ATP levels in mutant mice, and 
blockade of PGE2 synthesis in vivo by indomethacin normalized ENaC protein levels in the 
cortex but not in the medulla. Indomethacin also improved polyuria and hypokalemia and 
restored normal AQP2 and BKCa protein levels in mutant mice. Further, pharmacological 
inactivation of the proton pump in β-ICs induced release of PGE2 through activation of 
calcium-coupled purinergic receptors. In the present study, we identify ATP-triggered PGE2 
paracrine signaling originating from β-ICs as a pivotal mechanism in the development of 
hydro-electrolytic imbalance associated with dRTA. These studies also challenge the existing 
paradigm on the exclusive role of PCs and offer the new view that ICs and PCs are both 
critical in maintaining sodium balance, and hence, normal vascular volume and blood 
pressure. 
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INTRODUCTION 
 
The distal parts of the nephron, i.e. the connecting tubule and the collecting duct, play 
a critical role in renal acid excretion, and hence, in acid-base homeostasis (1, 2). Acid 
secretion is achieved by α-intercalated cells (α-ICs), a highly specialized renal cell type 
expressing an apical vacuolar H+-ATPase (v-H+-ATPase) and a basolateral Cl-/HCO3- 
exchanger kAE1 (3, 4). Protons generated from the hydration of CO2 within these cells are 
extruded actively across the apical membrane by the pump, while bicarbonate ions, which are 
also produced by this process, are translocated across the basolateral membrane by AE1. 
Dysfunction of either the pump or the anion exchanger can block proton secretion (1, 2). This 
failure of α-IC to decrease urine pH results in insufficient acid excretion and accumulation of 
acid in the body. This defect characterizes "classical" (or type 1) distal renal tubular acidosis 
(dRTA). Accordingly, inactivating mutations of ATP6V1B1 (5) or ATP6V0A4 (6) genes, 
which encode the Β1 or the a4 subunits of the proton pump, respectively, or mutations of 
SLC4A1 (7, 8), the gene encoding for the Cl-/HCO3- exchanger kAE1 have been identified in 
patients with the inherited form of type I dRTA (4).  
The characteristics of dRTA are not limited to abnormal acid-base balance, i.e. to 
acidemia of variable intensity, but often include a salt- and potassium-losing nephropathy that 
may lead to renal hypokalemia and dehydration (9, 10). dRTA is also almost invariably 
complicated by a marked hypercalciuria resulting in kidney stones, bone demineralization, 
nephrocalcinosis, and ultimately chronic renal failure. Since α-ICs are dedicated to acid 
secretion and are not thought to play a role in sodium absorption or in potassium secretion, 
the pathophysiology of the aforementioned sodium and potassium losses observed in patients 
suffering from dRTA is not well understood. These losses were initially believed to be 
consecutive to a direct effect of acidosis to depress several transporters along the nephron 
(11). However, Sebastian et al. demonstrated that sustained correction of acidemia in patients 
suffering from type I dRTA does not reverse the abnormalities in renal sodium or potassium 
handling (9, 10). Based on these observations, the authors concluded that impairments in renal 
sodium and potassium conservation may not be a reversible consequence of acidosis but 
instead may be consecutive to chronic interstitial nephropathy and nephrocalcinosis. 
However, the molecular defects that lead to inactivation of the proton pump, i.e., inactivating 
mutations of ATP6V1B1 or ATP6V0A4, which are frequent mutations observed in human 
patients, are not expected to affect only α-ICs. In fact, the proteins encoded by these genes are 
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also expressed by the β (or base-secreting) subtype of IC (β-ICs) that is also present in the 
distal nephron (12, 13). These cells share some of the characteristics with the α-ICs but with 
an opposite polarity, i.e., they express the v-H+-ATPase basolaterally and the Cl-/HCO3- 
exchanger pendrin (SLC26A4) at their apical membrane (14). Until recently, β-ICs were 
thought to be exclusively involved in base secretion. However, this paradigm has been 
challenged by recent observations showing that β-ICs exhibit electroneutral NaCl absorption 
(15, 16) and participate in the renal regulation of extracellular volume and blood pressure (17, 
18). In β-ICs, apical Cl- influx, which occurs through the Cl-/HCO3- exchanger Pendrin, is 
linked to apical Na+ influx by the Na+-driven Cl-/HCO3- exchanger NDCBE (15, 16). Thus, in 
theory, mutations that affect directly the proton pump are expected to impair both α-IC and β-
IC functions, and thereby affecting not only acid secretion but also NaCl absorption. 
Finberg et al. generated a mouse model with disruption of the Atp6v1b1 gene encoding 
for the β1 subunit of the H+-ATPase as a model of human dRTA. As expected from human 
studies, mice with Atp6v1b1 disruption (Atp6v1b1-/-) exhibit an impaired response to acid-
loading (19). However, these mice slightly differ from patients in that they do not have overt 
acidemia under standard laboratory conditions. They also do not exhibit hypercalciuria, and 
they develop neither nephrocalcinosis, nor interstitial nephritis. Hence, these knockout mice 
represent an interesting model to study the mechanisms that account for impaired sodium and 
potassium conservation in patients with dRTA consecutive to dysfunction of the proton pump, 
and particularly, to assess the involvement of β-IC dysfunction in this model.  
Therefore, our goal was to determine whether Atp6v1b1 disruption leads to a salt- and 
potassium-losing nephropathy as observed in human dRTA, and then to determine the 
mechanisms by which dysfunction of the proton pump affects the transport of Na+, Cl- and 
K+. Here we report that impaired renal sodium and potassium conservation observed in type I 
dRTA is not the consequence of acidosis or of chronic interstitial nephritis, but is instead the 
consequence of the proton pump defect in β-ICs. We demonstrate that in mice with Atp6v1b1 
disruption β-ICs impair functions of neighboring principal cells, which normally transport 
sodium, water and potassium, through paracrine ATP/PGE2 signaling cascade.  Furthermore, 
gain of ATP-triggered PGE2 signaling alters electrolytes and water balance in a paracrine 
manner. Beyond the inherited distal tubular acidosis, our findings also challenge the existing 
paradigm on the exclusive role of PCs and offer the new view that ICs and PCs are both 
critical in maintaining sodium balance, and hence, normal vascular volume.  
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RESULTS 
 
Atp6v1b1-/- mice have an impaired ability to conserve Na+, Cl-, K+, and water despite the 
absence of interstitial nephritis or nephrocalcinosis 
To test whether the Atp6v1b1-/- mice have an impaired renal ability to conserve Na+ and Cl-, 
physiological blood and urine parameters were measured in Atp6v1b1-/- mice and their wild-
type counterparts (Atp6v1b1+/+) that were pair-fed either a normal (0.3% Na+) or a Na+-free 
diet (all data are summarized in Table S1). As shown in Figure 1, urinary excretion of Na+ 
and Cl- was similar in both groups when the animals were fed a normal diet. During the first 
24-hr of NaCl restriction, Atp6v1b1-/- mice excreted more Na+ (Figure 1A) and Cl- (Figure 1B) 
than pair-fed wild-type mice. However, within 3 days of NaCl restriction, all mice reached 
steady state resulting in similar rates of Na+ and Cl- excretion in both genotypes. We also 
observed that Atp6v1b1-/-, even when fed a normal salt diet, exhibited hallmarks of vascular 
dehydration as evident from increased plasma renin activity (Figure 1C) and plasma protein 
concentrations (45.7 ± 0.8 g/l in Atp6v1b1+/+ n=10, vs. 50.2 ± 1.2 g/l in Atp6v1b1-/-, n=9; p = 
0.005) (Table S1). In addition, Atp6v1b1-/- mice exhibited lower systolic blood pressure  
(112.4 ± 2.8 mmHg in Atp6v1b1+/+ vs. 95.4 ± 2.5 mmHg in Atp6v1b1-/-, n=10 and 6, 
respectively; p<0.001). The development of marked secondary hyperaldosteronism in 
Atp6v1b1-/- mice subjected to NaCl restriction (Figure 1D) further suggests the presence of 
vascular dehydration in these animals. Taken together, these observations indicate that 
Atp6v1b1-/- mice have vascular dehydration and an impaired renal ability to conserve both Na+ 
and Cl-, and hence, that they have a salt-losing nephropathy.  
Under basal conditions Atp6v1b1-/- mice exhibited a lower plasma K+ concentration (Figure 
1E) than control mice, but an inappropriately normal urinary excretion of K+ (Figure 1F). 
Moreover, when animals were subjected to NaCl restriction (i.e., under conditions of maximal 
stimulation of aldosterone), urinary excretion of K+ in mutant animals was exacerbated and 
became higher, i.e., inappropriate for hypokalemia, than in controls (Figure 1F), 
demonstrating a renal defect in K+ conservation.  
In addition, we noticed that Atp6v1b1-/- mice exhibited polyuria that was also dramatically 
magnified by salt restriction (Figure 1G). Figure 1H shows that urine produced by Atp6v1b1-/- 
mice had a lower osmolality (1160 ± 124 mOsmol/kg; n = 7) than that of wild-type mice 
(2151 ± 31 mOsmol/kg; n = 8) under a normal Na+ diet. Na+-depleted diet had no significant 
effect on urine osmolalities (2437 ± 236 mOsmol/kg; n = 8 wild-type mice and 971 ± 211 
mOsmol/kg; n = 6 knock-out mice).  
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These experiments demonstrate that Atp6v1b1 disruption leads to a complex tubulopathy, 
which recapitulates major features observed in some patients suffering from classic type I 
dRTA and which have been attributed to chronic interstitial nephritis. However, careful 
examination by light microscopy of kidney sections from Atp6v1b1-/- mice demonstrated the 
absence of interstitial nephritis, and no evidence of microscopic nephrocalcinosis was found 
in sections examined after Von Kossa staining (Figure S1).  
 
Atp6v1b1 gene deletion inhibits ENaC in the CCD but not in the MCD 
Atp6v1b1 disruption leads to markedly reduced proton pump activity in α-ICs (19, 20) and 
possibly also in β-ICs. Pharmacological blockade of the pump has been shown to inhibit 
pendrin-dependent Cl- absorption by CCDs (21). Therefore, we hypothesized that Atp6v1b1 
disruption should reduce the electroneutral NaCl transport system via β-ICs that we recently 
described and that requires normal pendrin activity (16). To test this hypothesis, Na+ and Cl- 
transepithelial fluxes (JNa and JCl) were measured in CCDs isolated from Atp6v1b1-/- mice fed 
either a normal or a low salt diet. In a previous study, we have shown that CCDs isolated from 
wild type mice fed a normal salt diet do not exhibit any detectable transport activity, whereas 
CCDs isolated from mice fed a salt depleted diet absorb NaCl through the epithelial Na+ 
channel ENaC in principal cells and the pendrin/Ndcbe transport system in intercalated cells 
(16). As Atp6v1b1-/- mice fed a normal salt diet exhibited higher plasma renin activity (similar 
to that of wild type mice maintained on salt depleted diet for six days), one could have 
expected their CCDs to absorb NaCl as those from wild type mice maintained on a salt 
depleted diet. However, CCDs isolated from Atp6v1b1-/- mice were not able to absorb Na+ or 
Cl- (JNa = -4.23 ± 4.43 and JCl = -4.05 ± 6.92 pmol/min/mm ; n = 5). This was also the case for 
CCDs isolated from Atp6v1b1-/- mice fed a salt depleted diet (Figure 2A). JNa and JCl were 
approximately ten-fold less than in Atp6v1b1+/+ mice fed a salt depleted diet. These results 
suggest that in addition to impairing electroneutral Na+ absorption through ICs, Atp6v1b1 
disruption also inhibits Na+ absorption mediated by ENaC through the neighboring principal 
cells. Since ENaC is expressed exclusively in principal cells, Atp6v1b1 disruption was not 
expected to affect directly electrogenic Na+ absorption by CCD. 
To dissect the mechanisms by which Atp6v1b1 disruption impairs NaCl reabsorption in the 
CCD, we next performed semiquantitative immunoblotting to measure pendrin and ENaC 
protein abundance in the renal cortex of Atp6v1b1-/- mice under basal conditions. Figure 2B 
shows that abundances of both α-ENaC (left panel) and γ-ENaC (middle panel) were 
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approximately 50% lower in knock-out mice than in wild type mice. Pendrin protein level 
was reduced by 80% when compared to controls (Figure 2B, right panel). Data are 
summarized in Table 1. Taken together, our results demonstrate that Atp6v1b1 disruption 
inhibits electroneutral NaCl absorption by reducing pendrin expression in β-IC, but also 
impairs principal cell function by decreasing ENaC expression and function. Of interest, mice 
with gene disruption of pendrin have been shown to exhibit similar alterations in ENaC 
abundance as Atp6v1b1-/- mice (22). We next studied the effects of Atp6v1b1 disruption in the 
medullary collecting duct (MCD), a nephron segment that contains exclusively principal cells 
and α-ICs but does not have β-ICs. Figure 2C and Table 1 show that in the renal medulla, in 
contrast to our observations in the renal cortex, abundance of both α and γ subunits of ENaC 
were dramatically increased in knock-out mice, as expected from mice with secondary 
hyperaldosteronism. Unfortunately, we could not measure Na+ fluxes in MCDs, as this 
segment is not easily accessible for in vitro microperfusion. Alternatively, we estimated total 
ENaC activity in Atp6v1b1-/- mice by assessing the effects of an acute injection of amiloride 
(1.45 mg/kg of body weight) on urinary excretion of Na+. Amiloride injection significantly 
increased urine Na+ excretion in both genotypes and was only slightly less effective in 
Atp6v1b1-/- mice than in controls (Figure 2, panel D) indicating that ENaC-dependent Na+ 
absorption in the distal nephron is slightly lower in Atp6v1b1-/- mice. These results suggest 
that decreased ENaC activity in the CNT/CCD is almost fully compensated by increased 
ENaC activity in the MCD. In summary, our results show that β-IC dysfunction consecutive 
to Atp6v1b1 disruption inhibits NaCl absorption and impairs the sensitivity of principal cells 
to renin-angiotensin-aldosterone system activation in the CCD, while principal cells in the 
MCD have a normal response to hyperaldosteronism. Our results strongly suggest that a 
factor originating from the β-IC locally reduces ENaC activity in the cortex. 
 
Atp6v1b1-null mice have increased expression of the large conductance calcium-activated 
potassium channel in collecting ducts. 
In the connecting tubule and the collecting duct, K+ secretion occurs through two types of 
apical K+ channels: the renal outer medullary K+ (ROMK) channel and the large conductance 
calcium-activated K+ channel (BKCa).  
Movement of K+ across the apical membrane through selective apical K+ channels required a 
favorable electrical driving force, which is provided by electrogenic reabsorption of Na+ 
through ENaC. Since ENaC was found up-regulated in the MCD (Figure 2C), we tested 
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whether K+ leak could occur through ROMK in the MCD of Atp6v1b1-/- mice. We next 
analyzed the abundance of ROMK protein in the medulla. As detailed in supplementary 
information (Figure S2, panel A), in the medulla, anti ROMK antibody detected a triplet 
around 37 kDa in which the upper band was shown to correspond to the molecular form of 
ROMK expressed exclusively in the collecting duct. We found that ROMK protein abundance 
was markedly increased in MCD from Atp6v1b1-/- mice (Table 1 and Figure S2, panel B). The 
large conductance calcium-activated K+ channel BKCa mediates the flow-induced K+ 
secretion in the collecting duct (23). Elevated urinary flow in Atp6v1b1-/- mice may activate 
BKCa channels and K+ secretion. When assessed by immunoblotting, the protein level of the 
α subunit of the BKCa channel was increased by 1.6 and 2.6-fold in cortical and medullary 
samples from Atp6v1b1-/- mice, respectively (Figure 3, panel A and Table 1). These results 
show increases in K+ channels expression in Atp6v1b1-/- mice, which parallel up-regulation of 
ENaC in the MCD.  
 
Expression of AQP2 was dramatically decreased in collecting ducts of Atp6v1b1-null mice  
Accumulation of aquaporin 2 (AQP2) in the apical plasma membrane increases water 
permeability of the collecting duct allowing water to be reabsorbed from the collecting duct 
lumen and increasing the concentration of the urine. Immunoblotting studies showed that 
renal medulla AQP2 protein level was dramatically reduced (by 70%) in Atp6v1b1-/- mice as 
compared with control mice (Figure 3B and Table 1). In the cortex, AQP2 protein level in 
Atp6v1b1-/- mice was decreased by 40 % (Figure S3, panel A and Table 1). These results were 
confirmed by immunofluorescence on kidney sections (Figure 3, panel C and Figure S3, panel 
B). These results suggest that water loss in Atp6v1b1-/- mice is likely a consequence of 
downregulation of AQP2. 
 
Abnormal prostaglandin E2 release impairs ENaC regulation in CCDs 
Increased urine prostaglandin E2 (PGE2) excretion is often associated with salt and water 
losing nephropathies (24). The collecting duct is a major site of PGE2 synthesis in the kidney, 
where PGE2 inhibits both salt and water absorption (25, 26). We next measured PGE2 
excretion in the urine of Atp6v1b1-/- mice and their controls. Urinary PGE2 was increased 2 
fold in Atp6v1b1-/- mice (Figure 4A). To test whether principal cell dysfunction in our model 
could arise from an abnormal PGE2 release, we treated Atp6v1b1-/- mice with indomethacin, 
an unselective inhibitor of cyclooxygenases, the enzyme responsible for prostaglandin 
generation. Urinary PGE2 excretion of Atp6v1b1-/- mice was significantly decreased 24 hours 
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after the first injection of indomethacin (5 mg/kg b.w./day) and a maximal 60 % decrease was 
observed after 2 days. At day 2, indomethacin improved the polyuria and normalized urine 
osmolality (Table 2), and abolished the difference in plasma potassium concentration (4.10 ± 
0.07 mM, n=25 Atp6v1b1+/+ mice vs 3.54 ± 0.08 mM, n=24 Atp6v1b1-/- mice, without 
indomethacin treatment; p<0.0001 and 4.11 ± 0.07 mM, n=24 Atp6v1b1+/+ mice vs 3.90 ± 
0.09 mM, n=27 Atp6v1b1-/- mice, following indomethacin treatment; NS). Urinary Na+ and 
K+ excretions also decreased in response to indomethacin treatment in mutant mice (Table 2). 
Indomethacin reduced differences in plasma renin activity (PRA) between wild type and 
mutant mice (PRA in Atp6v1b1-/- mice was 6 fold that of Atp6v1b1+/+ mice, without 
indomethacin, and only 2.3 fold that of Atp6v1b1+/+ mice, with indomethacin, p=0.047) and 
abolished the difference in hematocrit (41 ± 1 %, n=38 Atp6v1b1+/+ mice vs. 44 ± 1 %, n=40 
Atp6v1b1-/- mice, without indomethacin treatment; p<0.01 and 40 ± 1 %, n=16 Atp6v1b1+/+ 
mice vs. 39 ± 2 %, n=17 Atp6v1b1-/- mice, following indomethacin treatment; NS). 
Indomethacin treatment had no significant effect in wild type mice. Western blot analyses 
shown in Figures 5A and 5C indicate that protein abundance for α− and γ-ENaC in cortical 
homogenates was no longer down-regulated, and was even slightly higher for γ-ENaC in 
treated Atp6v1b1-/- mice when compared to control mice. In contrast, pendrin expression 
remained very low (Table 1) in treated Atp6v1b1-/- mice. Expression of α− and γ-ENaC in the 
medullary collecting duct was still increased in treated Atp6v1b1-/- mice (Figures 5B and 5D) 
when compared to control mice as well as the expression of ROMK (Table 1). These results 
demonstrate that abnormal ENaC regulation in the CCD is due to a disturbance in PGE2 
paracrine signaling, whereas the reduction of pendrin is a direct consequence of proton pump 
dysfunction. Expression of AQP2 was also normalized by indomethacin treatment in both 
cortical and medullary samples (Figures 5E and 5F and Table 1). After indomethacin 
treatment, the expression of the α subunit of the BKCa channel was not different from that of 
control mice in both cortical and medullary samples (Figures 5G and 5H and Table 1). All 
densitometric analyses of immunoblots are summarized in Table 1. Taken together, these 
results indicate that renal K+ loss in Atp6v1b1-/- mice is likely a consequence of activation of 
flow-activated BKCa potassium channels.  
 
Inactivation of the basolateral H+-ATPase induced ATP dependent prostaglandins E2 
release by the cortical collecting duct 
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The preceding experiments suggest that PGE2 reduced ENaC activity in CCD principal cells. 
To get a better insight into the mechanism by which PGE2 regulates ENaC function in CCD 
principal cells, we measured PGE2 release into the tubular fluid in freshly isolated 
microperfused wild type CCDs in response to pharmacologic inhibition of basolateral H+-
ATPases in β-ICs using the previously established PGE2 biosensor technique (27, 28). We 
used HEK cells overexpressing the calcium-coupled PGE2 receptor EP1 as PGE2 biosensors 
by loading them with Fluo-4/Fura Red to measure cytosolic calcium and positioning them in 
direct contact with the tubular fluid (Figure 6A). As shown in Figure 6B, addition of 
bafilomycin A1 to the bathing solution inhibiting basolateral H+-ATPases in β-ICs caused 
significant elevation in HEK-EP1 biosensor cell calcium indicating luminal PGE2 release. The 
selective EP1 receptor inhibitor SC51322 added to the luminal perfusate blocked 
bafilomycin-induced biosensor responses indicating PGE2 specificity (Figure 6B).  
Luminal ATP via activation of P2Y2 receptors is known to mediate inhibition of Na+ 
absorption via ENaC in mouse CCD (29, 30). Recent studies have shown that local ATP can 
act either directly or via a signaling cascade that involves generation of active prostanoids, 
particularly PGE2 (31-33), exerting natriuretic effects on the CCD. We thus tested the effect 
of the addition of the purinergic (ATP) receptor blocker suramin to the tubular perfusate and 
showed that bafilomycin-induced PGE2 release was prevented by suramin (Figure 6B). 
Similarly, addition of the ATP scavenger apyrase (50 U/ml) to the tubular perfusate abolished 
PGE2 biosensor responses consistent with its dependence on luminal ATP release (Figure 
6B). Of note, as PGE2, urinary ATP excretion was increased by 3.1 fold in Atp6v1b1-/- mice 
(Figure 4). Daily injection of indomethacin to Atp6v1b1-/- mice for two days, which 
normalized ENaC expression in the cortex (Figures 5A and 5C), had no significant effect on 
urinary ATP excretion (0.36 ± 0.12 pmol/min before vs 0.54 ± 0.20 pmol/min after 
indomethacin injection, N= 7) while decreasing PGE2 excretion by 60%. These results 
suggest that ATP had no direct effect on ENaC expression but rather acted through PGE2 
generation in our model.  
When CCDs were loaded with the calcium-sensitive ratiometric fluorophore pair Fluo-4 and 
Fura Red, the addition of bafilomycin to the bathing solution caused significant elevations in 
CCD [Ca2+]i, most significantly in ICs (Figure 6C). Suramin added to the tubular perfusate 
completely abolished the effects of bafilomycin (Figure 6D). These experiments evidence a 
significant intracellular calcium elevation in ICs, which reflects activation of luminal 
purinergic receptors in response to inactivation of the basolateral H+-ATPase. 
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Overall, inhibition of basolateral H+-ATPase in β-ICs leads to ATP release, which then 
triggers PGE2 release by acting on luminal calcium-coupled purinergic P2 receptors, 
presumably P2Y2 receptors, the main luminal P2 receptor subtype expressed in the distal 
nephron.  
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DISCUSSION 
 
Type 1 dRTA is associated with a salt- and potassium-losing nephropathy that can 
lead to renal hypokalemia and dehydration (9, 10). dRTA is also almost invariably 
complicated by a marked hypercalciuria resulting in kidney stones, bone demineralization, 
nephrocalcinosis, and ultimately chronic renal failure. Mice with disruption of the Atp6v1b1 
gene encoding the B1 subunit of the H+-ATPase develop an abnormal response to an acid-
load (19), which is the direct consequence of impaired proton secretion as expected from 
dysfunction of α-ICs. Our current results demonstrate that Atp6v1b1 deficient mice, like 
patients with severe type I dRTA, have a salt losing nephropathy that leads to severe vascular 
dehydration when the animals are fed a NaCl-depleted diet. However, in the absence of 
nephrocalcinosis, this cannot be attributed solely to chronic interstitial nephritis but instead 
reflects abnormal NaCl handling by renal epithelial cells. In a previous study (16), we showed 
that CCDs isolated from mice with secondary hyperaldosteronism absorb Na+ through ENaC 
in principal cells and through the Na+-driven Cl-/HCO3- exchanger NDCBE in intercalated 
cells. Cl- absorption has been shown to occur in β-ICs through the Na+-independent Cl-
/HCO3- exchanger pendrin (18, 34). Here, we demonstrate that, despite marked hypovolemia, 
CCDs isolated from Atp6v1b1 deficient mice did not absorb NaCl, indicating that ENaC and 
NDCBE/pendrin activities are both impaired. Accordingly, expressions of pendrin, α- and γ-
ENaC were decreased in the cortex of Atp6v1b1 deficient mice. Reduction in protein 
expression as assessed by immunoblotting of renal cortex likely reflects changes in ENaC and 
pendrin expression in the CNTs as well. In contrast, in the renal medulla, protein abundances 
of both α- and γ-ENaC were dramatically increased as expected in hypovolemic animals. In 
vivo injection of amiloride further shows that global ENaC activity was only slightly altered 
in these mice, indicating that increased ENaC activity in the MCD almost fully compensated 
for decreased ENaC activity in the CNT/CCD of Atp6v1b1-/- mice. We conclude that β-IC 
dysfunction consecutive to Atp6v1b1 disruption impairs the sensitivity of principal cells to 
renin-angiotensin-aldosterone system activation in the CCD, while principal cells in the MCD 
have a normal response to hyperaldosteronism. 
Unlike human dRTA patients, Atp6v1b1 deficient mice do not develop spontaneous 
acidosis. It has been shown that the B2 subunit, which is normally co-expressed with the B1 
subunit in intercalated cells, compensates for the lack of the B1 subunit of the H+-ATPase in 
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α-ICs and that its activity is sufficient to maintain acid-base homeostasis in Atp6v1b1-/- mice 
under basal conditions but not in conditions of acid load (20, 35) or stimulation of angiotensin 
II (36). Our data showing no electroneutral NaCl transport in the CCD of Atp6v1b1-/- mice 
suggested that the B2 isoform is not capable of compensating for the absence of B1 in β-ICs 
under all circumstances (normal and low salt diet), conditions that may require angiotensin II 
mediated regulation of H+-ATPases.  
Our results provide an explanation for hypokalemia in patients suffering from type 1 
dRTA. K+ is freely filtered at the glomerulus and is almost totally reabsorbed by the proximal 
tubule and the loop of Henle. The amount of K+ excreted by the kidney is then determined by 
mechanisms beyond the early distal tubule, where either reabsorption or secretion of K+ can 
occur. The two main mechanisms identified yet that account for K+ secretion in the distal 
nephron are the small conductance K+ channel ROMK and the large conductance, calcium-
activated potassium channel BK (BKCa) (37). Apical ROMK channels are expressed in 
principal cells and K+ secretion through ROMK channels depends on electrogenic Na+ 
transport. BK channels have been primarily detected in apical membrane of ICs (38, 39), 
where basolateral Na-K-2Cl cotransporters (40, 41) may provide a mechanism for K+ uptake, 
thereby allowing K+ secretion through these cells. It is unlikely that K+ secretion occurs 
through excessive activity of ROMK in CCD of Atp6v1b1-/- mice since ENaC activity in this 
tubule segment is blocked, as indicated by our microperfusion data (see figure 2A). 
Upregulation of ENaC in the OMCD of Atp6v1b1-/- mice is expected to drive excessive K+ 
secretion through ROMK. High luminal flow rates are known to enhance K+ secretion due to 
activation of BKCa channels (23). Thus, elevated urinary flow in mutant mice probably 
activates BKCa potassium channels and K+ secretion. In line with this hypothesis, we found 
that BKCa expression was increased in mutant mice and that a reduction of urinary flow in 
Atp6v1b1-/- mice by indomethacin normalized expression level of BKCa and decreased 
urinary K+ excretion in Atp6v1b1-/- mice. This data also indicates that PGE2, which 
antagonizes the actions of vasopressin in the distal nephron (26), is responsible for the 
dramatic decreased expression of the AQP2 water channel seen in Atp6v1b1-/- mice and hence 
their urinary concentration defect.  
Our findings showing differential regulation of ENaC in cortical connecting 
tubule/collecting duct system and medullary collecting duct suggest that ENaC expression 
and activity in the CNT and the CCD are modulated by β-ICs. This is in line with recent 
studies showing that pendrin-null mice have an impaired ability to conserve Na+ during 
dietary NaCl restriction and reduced ENaC expression (22). It has been shown that pendrin 
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can increase ENaC abundance and function in part by increasing luminal HCO3 concentration 
and/or pH (42). However, it is unlikely that this mechanism can fully explain reduced cortical 
ENaC activity and expression observed in Atp6v1b1 deficient mice. In fact, Atp6v1b1-/- mice 
exhibited much higher urinary pH than control mice (6.6 ± 0.03 vs 5.8 ± 0.02, n=7 and 8 
respectively, p<0.0001). Moreover, indomethacin, which decreased urinary PGE2 excretion in 
Atp6v1b1 deficient mice, normalized ENaC expression specifically in the renal cortex. 
Indomethacin also tended to decrease urinary Na+ excretion in these mice, and reduced 
differences in plasma renin activity and hematocrit between wild type and mutant mice. 
Furthermore, we demonstrate that inactivation of the H+-ATPase induces PGE2 release by 
isolated microperfused CCD. Considering these data, and because PGE2 has been repeatedly 
shown to decrease electrogenic Na+ transport in isolated and microperfused CCDs (25, 26, 
43), we propose that PGE2 production has a primary role in downregulating ENaC expression 
and function in the CCD of Atp6v1b1 deficient mice. This autocrine/paracrine function of 
PGE2 in regulating Na+ transport in the CCD has been recently evidenced in isolated and 
microperfused tubules by Flores et al. (44). The authors showed that indomethacin enhanced 
flow-stimulated Na+ absorption in microperfused CCDs and concluded that flow-activated 
PGE2 release inhibits Na+ absorption. Opposing regulations of ENaC in the CCD and the 
MCD highlight the importance of this paracrine PGE2 signaling in antagonizing the action of 
the renin–angiotensin–aldosterone-system on ENaC in the CCD.  
 The present studies demonstrate that PGE2 release by isolated micropefused CCDs in 
response to the preferential inactivation of the basolateral H+-ATPase requires activation of 
luminal G protein-coupled purinergic (ATP) receptor. Such ATP-induced PGE2 release has 
been observed in other cell types including astrocytes (33), vascular smooth vessel cells (31) 
and inner medullary collecting duct cells (32).  
In the mouse kidney, ATP-permeable hemichannel connexin 30 (Cx30), which has 
been localized solely to the apical membrane of β-ICs of the distal nephron (45), is involved 
in ATP release from the collecting duct cells (15, 28). More recently, pannexin 1 channels 
(Panx1), expressed at the apical membrane of ICs, has also been proposed to regulate ATP 
release as Panx1 deficient mice excrete less ATP than their wild type littermates (15, 46). 
Thus, ATP released via Cx30 and/or Panx1 is theorically available for autocrine and paracrine 
signaling to intercalated and principal cells, respectively. The calcium coupled P2Y2 receptor 
is the main luminal P2 receptor subtype expressed in the distal nephron and was located in 
principal cells using confocal microscopy imaging (47). With calcium imaging experiments 
on isolated CCDs, we also evidence a strong intracellular calcium elevation in ICs in response 
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to the preferential inactivation of the basolateral H+-ATPase, which was abolished in the 
presence of luminal suramin. These data strongly suggest that ICs themselves respond to 
purinergic signaling.  
In the collecting duct, luminal ATP via activation of P2Y2 receptors inhibits Na+ 
ENaC-dependent Na+ transport (29, 30). Activation of purinergic P2 receptors also decreases 
AVP-induced water permeability and down-regulates AQP2 (48, 49). Our experiments 
showing that indomethacin treatment restores normal protein levels of ENaC and AQP2 in the 
renal cortex of Atp6v1b1 deficient mice but has no effect on urinary ATP excretion suggests 
that ATP acts through PGE2 generation in CCDs of Atp6v1b1 deficient mice. However, we 
cannot rule out the possibility of a direct effect of ATP on ENaC activity through a reduction 
in channel open probability.   
The effects of PGE2 are mediated by a distinct class of G protein-coupled receptors 
referred to as E-prostanoid (EP) receptors. Among the three EP receptor subtypes that have 
been localized in the cortical collecting duct (e.g., EP1, EP3 and EP4 receptors), activation of 
EP1 receptors by basolateral PGE2 increases intracellular calcium levels and inhibits Na+ 
absorption in the in vitro microperfused cortical collecting duct (25). Basolateral PGE2 
through Gi protein coupled EP3 receptors inhibits vasopressin-stimulated water permeability 
of this epithelium (26). PGE2 produced by the cortical collecting cells and released across the 
basolateral membrane of these cells may enter the bloodstream by diffusing into the 
peritubular capillaries and could potentially circulate and activate their remote EP3 receptors 
in the medulla. Alternatively, activation of the renin-angiotensin-alsosteron system has been 
suggested to induce PGE2 synthesis in the renal medulla (50). In addition to this well-known 
basolateral effect of PGE2, there is evidence for luminal prostaglandin receptors in the cortical 
collecting duct, activation of which suppresses ENaC mediated Na+ transport (43). As 
indicated by our biosensor experiments, which measured luminal PGE2, PGE2 release also 
occurs through luminal cell membranes of the CCD. Luminal PGE2 has been reported to 
increase cAMP production in culture CCD cells (51, 52), suggesting that the effects of 
luminal PGE2 are mediated by Gs protein coupled EP receptors. EP2 and EP4 are coupled to 
the Gs protein and signal by increasing intracellular cAMP levels, but only the EP4 receptor 
has been localized in the cortical collecting duct (53). Thus, PGE2 release through luminal and 
basolateral cell membranes of the CCD may inhibit Na+ transport through activation of EP1 
and EP4 receptors and water transport through EP3 receptor activation. 
The importance of the intratubular paracrine factor ATP as a regulator of electrolytes 
and water balance in the distal nephron is emerging (15). In contrast to aldosterone, which is a 
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powerful stimulatory factor of Na+ absorption through PCs, ATP as PGE2 exert an inhibitory 
effect on Na+ absorption. The importance of these paracrine factors in blood pressure 
regulation is highlighted by previous studies showing that disruption of the purinergic P2Y2 
receptor or the microsomal prostaglandin E synthase 1, a key enzyme in PGE2 synthesis, leads 
to salt sensitive hypertension in mice (54, 55). In the present study, we identified β-ICs as an 
important site of ATP release, which triggers through P2Y2 receptor activation the local 
production and release of PGE2. We also show that β-ICs can down-regulate ENaC in the 
neighboring PCs through this PGE2/ATP signaling. Genetic ablation of connexin 30 in mouse 
causes salt-sensitive increase in blood pressure (28). Impairment of this paracrine signaling 
originating from β-ICs may be involved in the pathogenesis of several forms of salt sensitive 
hypertension. 
This paracrine ATP/PGE2 signaling originating from β-ICs for modulating Na+ 
absorption in the CCD seems well adapted to acutely modulate Na+ absorption in response to   
tubular NaCl overloading. Indeed, the distal nephron is challenged daily by variations in 
tubular fluid NaCl concentration as a direct consequence of dietary salt intake. Urinary ATP 
levels have been shown to increase with dietary Na+ intake (56, 57). We propose a paradigm 
where β-ICs would sense the increase in NaCl delivery to the distal nephron and in turn 
release ATP/PGE2 to decrease Na+ absorption by adjacent PCs. We have reported that pendrin 
is primarily regulated in response to chronic changes in Cl- balance (i.e., pendrin expression is 
decreased when Cl- excretion increases) (58, 59). Thus, coordinated inhibition of Na+ and Cl- 
absorption through both PCs and ICs will allow the body to get rid of the excess of NaCl 
brought about by the diet.  
In conclusion, we demonstrate that impaired renal sodium and potassium conservation 
observed in type 1 (or pump-defect type) dRTA is not the consequence of acidosis or of 
chronic interstitial nephritis, but is instead the consequence of the dysfunction of the proton 
pump in the β-IC. We propose a new paradigm where dysfunction of the proton pump in α-IC 
results in an acidification defect while dysfunction of the pump in β−IC is responsible for 
renal loss of NaCl, K+ and water (figure 7). In light of the present study, it would be of 
interest to measure urinary prostaglandin excretion in human dRTA patients in future studies 
and to determine whether indomethacin treatment would improve dehydration and 
hypokalemia in these patients. 
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METHODS 
 
Animals: Atp6v1b1-/- mice were kindly provided by Lifton R (Yale University, New Haven, 
CT, USA). Mice heterozygous for Atp6v1b1 gene disruption were crossed, and wild-type 
(Atp6v1b1+/+) and homozygous knockout mice (Atp6v1b1-/-) were genotyped in their 
offspring by PCR of tail biopsies. In all experiments, controls consisted of wild type 
littermates.  
 
Physiological studies: All experiments were performed using age- and sex-matched 
Atp6v1b1+/+ and Atp6v1b1–/– littermates mice (3-5 month-old). For urine collection, mice 
were housed in metabolic cages (Techniplast). Mice were given deionized water ad libitum 
and pair-fed with standard laboratory chow containing 0.3% of sodium (INRA). They were 
first allowed to adapt for 3-5 days to the cages. At steady state, urine collection was 
performed daily under mineral oil in the urine collector for electrolyte measurements. Mice 
were then switched to a NaCl free diet (INRA). After the switch, urines were collected for the 
6 first hours and for the subsequent 18 hours, and then each 24 hours for 7 days. Urine 
creatinine (modified kinetic Jaffé colorimetric method) was measured with a Konelab 20i 
auto-analyzer (Thermo Electron Corporation). Urinary chloride was measured with a DL 55 
titrator (Mettler Toledo). Urinary Na+ and K+ were measured by flame photometry (IL943, 
Instruments Laboratory). Urine osmolalities were measured with a freezing point osmometer 
(Roebling). Plasma renin concentration was determined by radioimmunoassay of angiotensin 
I generated by incubation of the plasma at pH 8.5 in the presence of an excess of rat 
angiotensinogen (60). Urine aldosterone was measured by RIA (DPC Dade Behring). Urinary 
prostaglandin E2 was measured by EIA (Prostaglandin E2 EIA kit, Cayman chemicals). 
Urinary ATP was measured on diluted urines with the FLAA kit from Sigma. Blood 
collection by tail incision on anesthetized mice by peritoneal injection of a mixture (0.1ml/g 
body weight) of ketamine (Imalgene®, Rhône Mérieux; 10%) and xylazine (Rompun®, 
Bayer AG; 5%) was performed for K+ measurement with an ABL 77 pH/blood-gas analyzer 
(Radiometer). Blood gases analyses were performed by retro-orbitary punction, and pH, 
PCO2, PO2, Na+ and Cl- were measured with an ABL 77 pH/blood-gas analyzer (Radiometer). 
Blood bicarbonate concentration was calculated from the measured values using the 
Henderson-Hasselbach equation.  
 18 
For indomethacin treatment, indomethacin (Sigma) dissolved in ethanol (10 % volume) and 
saline was injected intraperitonealy once a day for up to 6 days (5 mg/kg b.w./day). Urines 
were collected daily and keep frozen at -80°C. 
 
Blood-pressure measurements in conscious mice. Systolic blood pressure was measured in 
conscious mice fed a normal salt diet using a computerized tail-cuff system after 1 week of 
daily training, as described elsewhere (61). Then at least 10 measurements were performed 
every day for at least seven consecutive days. Only the last four days were kept for analyses. 
If the variability of the measurements made in a single day exceeded the SD by more than 
20%, this day was discarded and replaced by an additional day of measurement. This method 
has been extensively validated and correlates well with direct measurements of intra-arterial 
pressure (61). 
 
Immunoblot analyses: Animals were sacrificed with ketamine and xylazine (0.1 and 0.01 
mg.g of body weight-1, respectively). Kidneys were removed and cut into 5-mm slices and the 
cortex and medulla were excised under a stereoscopic microscope and placed into ice-cold 
isolation buffer (250 mM sucrose, 20 mM Tris-Hepes, pH 7.4) containing protease inhibitors 
in µg/ml: 4 aprotinin, 4 leupeptin, 1.5 pepstatin A and 28 4-(2- aminoethyl)-benzenesulfonyl 
fluoride (AEBSF). Minced renal tissues were homogenized in a Dounce homogenizer (pestle 
A, 5 passes) followed by 10 passes through a Teflon-glass homogenizer rotating at 1000 rpm. 
The homogenate was centrifuged at 1000 g for 10 min (rotor JS-13.1, Beckman), and the 
supernatant was centrifuged at 360,000 g for 40 min at 4°C (rotor 70.1 Ti, Beckman). The 
pellet was resuspended in isolation buffer. Protein contents were determined using the 
Bradford protein assay (microBradford, Bio Rad Laboratories). 
Membrane proteins were solubilized in SDS-loading buffer (62.5 mM Tris HCl, pH 6.8, 2% 
SDS, 100 mM dithiotreitol, 10% glycerol and bromophenol blue), incubated at room 
temperature for 30 min. Electrophoresis was initially performed for all samples on 7.5% 
polyacrylamide minigels (XCell SureLock Mini-cell, Invitrogen Life Technologies), which 
were stained with Coomassie blue to provide quantitative assessment of loading 
(Supplementary figure S4), as previously described (58). For immunoblotting, proteins were 
transferred electrophoretically (XCell II Blot Module, Invitrogen Life Technologies) for 1.5 h 
at 4°C from unstained gels to nitrocellulose membranes (Amersham) and then stained with 
0.5% Ponceau S in acetic acid to check uniformity of protein transfer onto the nitrocellulose 
membrane. Membranes were first incubated in 5% nonfat dry milk in phosphate-buffered 
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saline, pH 7.4 (PBS) for 1 h at room temperature to block nonspecific binding of antibody, 
followed by overnight at 4°C with the primary antibody (anti-Pendrin 1:10000; anti 
AQP2 1:100; anti α-ENaC 1:10000 ; anti γ-ENaC 1:30000; anti ROMK 1:2000 ; anti BKCa α 
subunit 1 :500 ; anti β-actin 1:500000) in PBS containing 1% nonfat dry milk.  After four 5 
min washes in PBS containing 0.1% Tween-20, membranes were incubated with 1:10000 
dilution of goat anti-rabbit IgG (Bio-Rad) or horse anti-goat IgG (Vector Laboratories, 
Burlingame, CA) conjugated to horseradish peroxidase in PBS containing 5% nonfat dry milk 
for 2 hours at room temperature. Blots were washed as above, and luminol-enhanced 
chemiluminescence (ECL, Perkin Elmer Life Science Products) was used to visualize bound 
antibodies before exposure to Hyperfilm ECL (Amersham). The autoradiography was 
digitized with the use of a laser scanner (Epson Perfection 1650, Epson), and quantification of 
each band was performed by densitometry using NIH Image software. Densitometric values 
were normalized to the mean for the control group that was defined as 100% and results were 
expressed as mean ± S.E. 
Antibodies against α and γ subunits of ENaC were a kind gift from J Loffing (University of 
Zurich, Zurich, Switzerland). Antibody against α-ENaC was raised against the N-terminus of 
mouse α-ENaC (MLDHTRAPELNLDLDLDVSNC)(62). Antibody against γ−ΕΝaC was 
described elsewhere (63). Antibodies against pendrin (64) were a gift from P Aronson (Yale 
University, New Haven, CN). Antibodies against aquaporin 2 used for immunoblotting were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies againt ROMK and 
BK α subunit were purchased from Alomone labs. Antibodies against β-actin were purchased 
from Abcam.  
 
Immunofluorescence labeling on kidney tissue: Mice kidneys were fixed in situ by perfusion 
of 4% paraformaldehyde in Phosphate Buffer Saline. Coronal kidney sections containing all 
kidney zones were then postfixed for 4–6 h at 4°C in 4% paraformaldehyde and then 
embedded in paraffin. Subsequently, 4-µm sections of the paraffin block were deparaffinized 
in toluene and rehydrated through graded ethanol. Rehydration was completed in Tris-
buffered saline (TBS), pH 7.6. Slides were then placed in a plastic tank filled with Target 
Retrieval Solution (Dako) and heated 45 min in a water bath at 98°C. These steps unmasked 
antigens and allowed immunostaining of paraformaldehyde-fixed paraffin sections, as 
determined in preliminary experiments (not shown). To reduce nonspecific binding, sections 
were rinsed in TBS for 10 min and incubated with background-reducing buffer (Dako) for 20 
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min. Mice kidney sections were then labeled with the rabbit polyclonal AQP2 antibody as 
follows. Anti-AQP2 was applied for 1 h at room temperature. After three washes, sections 
were incubated with a 1:1000 dilution (in background-reducing buffer) of donkey anti-rabbit 
IgG coupled to CyTM3 (Jackson Immunoresearch Laboratories Inc) in TBS, 30 min at room 
temperature, followed by three TBS washes. Rabbit anti AQP2 antibodies (AQP2 H7661) 
were a gift from S Frische (Aarhus University, Aarhus, Denmark) and were used by De 
Seigneux et al. (65). 
 
In vitro microperfusion of mouse CCDs and transepithelial ion fluxes measurement: 
Kidneys were removed, and cut into 1 to 2 mm coronal slices that were transferred into a 
chilled dissection medium containing (in mM): 118 NaCl, 25 NaHCO3, 2.0 K2HPO4, 1.2 
MgSO4, 2.0 calcium lactate, 1.0 sodium citrate, 5.5 glucose, and 12 creatinine, pH 7.4, and 
gassed with 95% O2-5% CO2. CCD segments were isolated from cortico-medullary rays 
under a dissecting microscope with a sharpened forceps. Because CCDs are highly 
heterogeneous, relatively short segments (0.45-0.6 mm) were dissected to maximize the 
reproducibility of the isolation procedure. In vitro microperfusion was performed as described 
by Burg et al. (66): isolated CCDs were rapidly transferred to a 1.2 ml temperature- and 
environmentally-controlled chamber, mounted on an inverted microscope, and then perfused 
and bathed initially at room temperature with dissection solution. The specimen chamber was 
continuously suffused with 95% O2-5% CO2 to maintain pH at 7.4. Once secure, the inner 
perfusion pipette was advanced, and the tubule was opened with a slight positive pressure. 
The opposite end of the tubule was then pulled into a holding collection pipette. In the 
holding collection pipette, 2 to 3 cm of water-saturated mineral oil contributed to maintain the 
tubule open at a low flow rate of perfusion. The perfusing and collecting end of the segment 
was sealed into a guard pipette using Dow-Corning 200 dielectric fluid (Dow Corning Corp.). 
The tubules were then warmed to 37°C and equilibrated for 20 minutes while the collection 
rate was adjusted to a rate of 2 nl/min. The length of each segment was measured using an 
eyepiece micrometer. Because CCDs from mice are frequently unstable and collapse rapidly, 
measurements were conducted during the first 90 minutes of perfusion. Usually, collections 
from 4 periods of 15 minutes were performed in which 25 to 30 nanoliters of fluid were 
collected. The volume of the collections was determined under water-saturated mineral oil 
with calibrated volumetric pipettes. For [Na+] and [creatinine] measurements, 20 nl were 
required, while 2–3 nanoliters were used for [Cl–] determinations. 
 [Na+] and [creatinine] measurements were performed by HPLC and [Cl–] was measured by 
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microcoulometry as previously described (16, 67, 68). 
Creatinine was used as the volume marker, and therefore was added to the perfusion solutions 
(both perfusate and bath) at a concentration of 12 mM. The rate of fluid absorption (Jv) was 
calculated as Jv = (Vperf – Vcoll)/L, with Vperf = Crcoll/Crperf x Vcoll. 
Crcoll and Crperf are the concentrations of creatinine in the collected fluid and perfusate, 
respectively. Vcoll is the collection rate at the end of the tubule. L is the length of the tubule. 
For each collection, Na+ flux (JNa) was calculated and reported to the length of the tubule (L): 
JNa =[( [Na]perf x Vperf )– ([Na]coll x Vcoll )] /L and JCl = [([Cl]perf × Vperf) – ([Cl]coll × 
Vcoll)]/L, where “perf” indicates perfusate and “coll” indicates collection fluid. Therefore, 
positive values indicate net absorption, whereas negative values indicate net secretion of the 
ion. For each tubule, the mean of the 4 collection periods was used. 
 
Fluorescence microscopy: The [Ca2+]i of HEK/EP1 biosensor cells was measured as 
described previously (27). On average, 3-4 HEK/EP1 biosensor cells were placed at the 
tubule exit, and almost all biosensor cells produced PGE2-induced calcium elevations. 
 
Statistics: Experimental results are summarized as mean ± SEM. All statistical comparisons 
were made by use of unpaired Student’s t test (two-tailed) or by ANOVA followed by a 
Bonferroni’s post-hoc test when appropriate. A P value less than 0.05 was considered 
significant. 
 
Study approval: All the experimental procedures have been approved by the local ethic 
committee from University Pierre et Marie Curie (agreement Ce5/2010/053) and were 
performed in accordance with the Guide for the Care and Use of Laboratory Animals (NIH 
publication No.93-23, revised 1985) and with the French Government animal welfare policy 
(Agreement number RA024647151FR). 
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FIGURE LEGENDS 
 
 
Figure 1: Effects of dietary NaCl restriction and renal K+ and water handling in 
Atp6v1b1-/- mice. A. Time course of renal excretion of Na+ in Atp6v1b1-/- and Atp6v1b1+/+ 
mice fed a normal salt diet and then switch to a NaCl restricted diet. B. Time course of renal 
Cl- excretion. C. Plasma renin concentration was measured under a normal salt diet, or after 6 
days of NaCl restriction. D. Time course of urinary excretion of aldosterone. E. Plasma [K+] 
was measured in Atp6v1b1-/- and Atp6v1b1+/+ mice fed a normal salt diet or after 6 days of 
NaCl restriction. F. Time course of renal K+ excretion when animals used for measurements 
of plasma [K+] shown in panel E were switched from normal to NaCl-restricted diet. G. Time 
course of urine output. H. Time course of urine osmolality. Data are presented as means ± 
S.E.; n = 8 for Atp6v1b1+/+ and 7 for Atp6v1b1-/-. Statistical significance was assessed by 
unpaired Student’s t-test. * p<0.05 , ** p<0.01 and ***p<0.001 vs. Atp6v1b1+/+ 
 
Figure 2: Differential effects of Atp6v1b1 disruption on the cortical and medullary 
collecting duct. A. Effects of Atp6v1b1 disruption on NaCl transport in the cortical collecting 
duct. Na+ (JNa) and Cl- (JCl) transepithelial fluxes were measured in CCDs isolated from 
Atp6v1b1+/+ mice (white bars) or Atp6v1b1-/- mice (black bars) fed a salt depleted diet for two 
weeks before the experiments. Statistical significance was assessed by 2-tailed unpaired 
Student’s t test. N= 5 to 7 tubules from different mice in each group. *P<0.05. ***P<0.001. 
B. Effects of Atp6v1b1 disruption on ENaC and pendrin expression in the cortical collecting 
duct. α-ENaC (left), γ-ENaC (middle) and pendrin (right) protein abundance was assessed by 
western blot of protein extracted from the renal cortex of Atp6v1b1-/- (black bars) and 
Atp6v1b1+/+ mice (white bars). C. Effects of Atp6v1b1 disruption on ENaC expression in the 
medullary collecting duct. α-ENaC (left) and γ-ENaC (middle) protein abundance was 
assessed by Western blot of protein extracted from the renal medulla of Atp6v1b1-/- (black 
bars) and Atp6v1b1+/+ (white bars) mice. For panels B and C, each lane was loaded with a 
protein sample from a different mouse. 15 µg and 5 µg proteins were loaded per gel lane in B 
and C, respectively. Equal loading was confirmed by parallel Coomassie-stained gels. The α-
ENaC antibody recognized two bands at 90 and 100 kDa. Only the 90 kDa (arrow) was not 
detected in kidneys from α-ENaC knock-out mice and therefore quantified. The γ-ENaC 
antibody recognized a doublet band at 85-80 kDa and a large band centered around 70 kDa 
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(bracket). Bar graphs show summary of densitometric analyses of the summation of the 
doublet band (85 kDa) and the broad 70 kDa band. Statistical significance was assessed by 
unpaired Student’s t-test. *P<0.05, **P<0.01, ***P<0.001 vs. Atp6v1b1+/+. D. Effect of 
amiloride on urinary Na+ excretion in Atp6v1b1+/+ and Atp6v1b1-/-mice. Urines were collected 
before and 6 hours after amiloride injection (1.45 mg/kg body weight) to Atp6v1b1+/+ and 
Atp6v1b1-/-mice. Statistical significance was assessed by One way ANOVA. *** P<0.001 and 
** P<0.01 vs. basal state. * P<0.05, Atp6v1b1-/- vs Atp6v1b1+/+ mice after amiloride injection. 
 
Figure 3: BKCa and AQP2 protein expression assessed in Atp6v1b1-/- and Atp6v1b1+/+ 
mice. A. Western blot for αBKCa on renal cortex (left) or renal medulla (right). Each lane 
was loaded with a protein sample from a different mouse. 15 µg and 5 µg proteins were 
loaded per gel lane for cortical samples and medullary samples, respectively. B. Western blot 
for AQP2 on renal medulla. Bracket and asterisk show the glycosylated 37 kDa and the 
unglycosylated 25 kDa forms of AQP2, respectively. Each lane was loaded with a protein 
sample from a different mouse. 5 µg proteins were loaded per gel lane. Equal loading was 
confirmed by parallel Coomassie-stained gels. For A and B, bar graphs show summary of 
densitometric analyses. For AQP2, bar graphs show the summation of bracketed and 
asterisked bands. Statistical significance was assessed by unpaired Student’s t-test. *** P<0. 
01 vs. Atp6v1b1+/+. C. Immunohistochemistry on kidney sections showing AQP2 staining in 
renal medulla from Atp6v1b1+/+ (upper panel) and Atp6v1b1-/-  (lower panel) mice. Scale bars: 
250 µm. 
 
Figure 4: Effects of Atp6v1b1 disruption on urine excretion of PGE2 and ATP. Urinary 
excretion of PGE2 (panel A) and ATP (panel B) in Atp6v1b1-/- and Atp6v1b1+/+ mice. Data are 
the means ± S.E. For PGE2, N= 26 to 27 mice in each group. For ATP, N= 15 mice in each 
group. Statistical significance was assessed by unpaired Student’s t-test with Welch’s 
correction. ** P<0.01 vs. Atp6v1b1+/+ ; *** P<0.001 vs. Atp6v1b1+/+. 
 
Figure 5: Effects of 2 days of indomethacin injection on the protein abundance of ENaC, 
AQP2 and BKCa in Atp6v1b1-/- and Atp6v1b1+/+ mice. Protein abundance of α-ENaC 
subunit (A and B), γ-ENaC subunit (C and D), AQP2 (E and F) and αBKCa (G and H) was 
assessed by Western blot of protein extracted from renal cortex (A, C, E and G) or medulla 
(B, D, F and H) of Atp6v1b1-/- (black bars) and Atp6v1b1+/+ (white bars) mice after 2 days of 
indomethacin injections. Each lane was loaded with a protein sample from a different mouse. 
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15 µg and 5 µg proteins were loaded per gel lane for cortical samples and medullary samples, 
respectively. Equal loading was confirmed by parallel Coomassie-stained gels. Bar graphs 
show summary of densitometric analyses. *** p<0.001  vs. Atp6v1b1+/+. In A and B, arrow 
indicates the 90 kDa specific band for α-ENaC. In E and F, bar graphs show the summation 
of bracketed (glycosylated 37 kDa form of AQP2) and asterisked (unglycosylated 25 kDa 
form of AQP2) bands.  
 
Figure 6: Paracrine signaling in the isolated microperfused cortical collecting duct. A 
and B. Measurement of bafilomycin A1-induced luminal PGE2 release in the isolated 
microperfused cortical collecting duct using a biosensor technique. A. HEK cells 
overexpressing the calcium-coupled PGE2 receptor EP1 were loaded with the calcium-
sensitive ratiometric fluorophore pair Fluo-4 and Fura Red, held by a holding pipette (HP1) 
and positioned in the lumen of the split-open microperfused connecting tubule-collecting duct 
in direct contact with the tubular fluid. PP: CCD perfusion pipette; HP2: a second holding 
pipette helped to keep the tubule-end in position. DIC image and fluorescence overlay are 
shown. B. Summary of PGE2 biosensor responses. Fold change in Fluo-4/Fura Red 
fluorescence ratio is shown as index of PGE2 release. Addition of 40 nM bafilomycin (Baf) to 
the bathing solution caused significant elevation in HEK-EP1 biosensor cell calcium 
indicating luminal PGE2 release. The effects of bafilomycin were prevented by the addition of 
the purinergic (ATP) receptor blocker suramin (50 µM) to the tubular perfusate. Similarly, the 
selective PGE2 EP1 receptor inhibitor SC51322 or SC (10 µM) added to the luminal perfusate 
blocked bafilomycin-induced biosensor responses indicating PGE2 specificity. Addition of the 
ATP scavenger apyrase (50 U/ml) to the tubular perfusate also abolished PGE2 biosensor 
responses consistent with its dependence on luminal ATP release. *: P<0.05 baf vs baseline 
(ctrl), n numbers per group are indicated in parentheses. C and D. Fluorescence imaging of 
bafilomycin-induced purinergic calcium signaling in the isolated microperfused cortical 
collecting duct. CCDs were perfusion-loaded with the calcium-sensitive ratiometric 
fluorophore pair Fluo-4 and Fura Red. C. Gradient pseudocolor images show CCD 
intracellular calcium ([Ca2+]i) levels before (left panel) and after (right panel) the addition of 
40 nM bafilomycin to the bathing solution. Bafilomycin caused significant elevations in CCD 
[Ca2+]i, most significantly in ICs, which were identified based on anatomical considerations 
(lower cell density and higher cell volume compared to PCs). D. Summary of bafilomycin-
induced changes in CCD [Ca2+]i. The purinergic (ATP) receptor blocker suramin added to the 
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tubular perfusate (50 µM) completely abolished the effects of bafilomycin. *: P<0.05 
bafilomycin vs bafilomycin and suramin, n number per group is 5. 
 
Figure 7: Schematic description of the consequence of vH-ATPase dysfunction on Na+, 
K+ and water transport in the CNT/CCD and the MCD. Atp6v1b1 disruption impairs both 
electroneutral Na+ absorption through β-ICs and ENaC-mediated Na+ absorption through the 
neighboring principal cells (PC). Local ATP/PGE2 signaling cascade is responsible for 
decreased ENaC protein and activity as well as AQP2 protein and contribute to Na+ and water 
losses, thereby promoting high tubular flow. ENaC inhibition in the CNT/CCD likely blocks 
K+ secretion through ROMK. In contrast, principal cells in the MCD have a normal response 
to hyperaldosteronism (i.e. increased ENaC expression). Increased ENaC activity in MCD is 
expected to favor K+ secretion through ROMK. High tubular flow activates BKCa potassium 
channels and K+ secretion, leading to renal K+ loss in Atp6v1b1-/- mice. Indeed, indomethacin, 
which reduced urinary flow and restored AQP2 protein levels in Atp6v1b1-/- mice, also 
normalized protein levels of BKCa and decreased urinary K+ excretion in Atp6v1b1-/- mice, 
leading to normal plasma potassium concentration.  
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Table 1: Summary of densitometric analyses of immunoblots on renal cortex and medulla 
homogenates from Atp6v1b1+/+ and Atp6v1b1-/- mice without treatment and during 
indomethacin treatment (5 mg/kg/d for 48 hours) fed a normal diet (0.3% Na+). 
 
 
No treatment 48h indomethacin 
CORTEX 
Atp6v1b1+/+ (n=7) Atp6v1b1-/- (n=7) Atp6v1b1+/+ (n=6) Atp6v1b1-/- (n=6) 
αENaC 100 ± 9.0 48.0 ± 3.0*** 100 ± 7.1 74.6 ± 10.4 
γENaC (total) 100 ± 4.8 46.7 ± 9.3*** 100 ± 4.1 104.6 ± 4.1 
Pds 100 ± 11.8 13.3 ± 3.3*** 100 ± 3.3 16.5 ± 4.4*** 
AQP2 (total) 100 ± 7 59 ± 13* 100 ± 8.6 137.3 ± 19.5 
BK α subunit 100 ± 9 163.3 ± 5.2*** 100 ± 4.6 97.6 ± 3.4 
β-actin 100 ± 6.2 107.2 ± 4.6 100 ± 6.2 101.4 ± 4.0 
No treatment 48h indomethacin 
MEDULLA 
Atp6v1b1+/+ (n=7) Atp6v1b1-/- (n=7) Atp6v1b1+/+ (n=6) Atp6v1b1-/- (n=6) 
αENaC  100 ± 18.9 231.6 ± 13.1*** 100 ± 23.9 362.6 ± 23.1*** 
γENaC (total) 100 ± 8.8 188.8 ± 18.5*** 100 ± 11.3 193.2 ± 12.4*** 
AQP2 (total) 100 ± 3.0 30.1 ± 8.3*** 100 ± 7.1 78.4 ± 13.1 
BK, α subunit 100 ± 10 258.8 ± 14*** 100 ± 11.1 101.3 ± 4.0 
ROMK  100 ± 21 176 ± 10** 100 ± 24 185 ± 5** 
β-actin 100 ± 5.7 103.6 ± 5.5 100 ± 11.6 114 ± 4.3 
Values are the means ± S.E. (n)= number of mice per group. Statistical significance between 
groups  was determined by unpaired Student’s t-test. * p<0.05 ; **p<0.01 ; ***p≤0.001 vs 
wild type mice. 
 
 
 
 
 
Table 2: Physiological parameters from Atp6v1b1-/- mice before and during indomethacin 
treatment 
 
 Basal state 24h indomethacin 48h indomethacin 
Weight, g 24.4 ± 0.6 25.2 ± 0.6 25.0 ± 0.7 
Food intake, g 4.18 ± 0.19 4.07 ± 0.24 3.79 ±0.23 
Water intake, ml 7.69 ± 0.81 7.17 ±0.73 6.72 ± 0.39 
Urine output, ml/24H 2.73 ± 0.2 1.97 ± 0.18** 1.98 ± 0.21* 
Urine Osmolality, mosm/l 1564 ± 70 2048 ± 134** 1986 ± 122** 
Urine Na, µmol /24H 248 ± 13 173 ± 31* 200 ± 33 
Urine K, µmol/24H 697 ± 24 596 ± 50 574 ± 38* 
Values are the means ± S.E. N= 12 mice. Statistical significance between groups was 
determined by unpaired Student’s t-test. * p<0.05 vs basal state. ** p≤0.01 vs basal state 
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Table S1: Physiological blood parameters from Atp6v1b1+/+ and Atp6v1b1-/- mice fed a 
normal diet (0.3% Na+) or a low Na+ diet (0% Na+) 
 
 0.3 % Na+ 0 % Na+ 
 Atp6v1b1+/+ Atp6v1b1-/- Atp6v1b1+/+ Atp6v1b1-/- 
pH 7.23 ± 0.01 (10) 7.26 ± 0.01 (9) 7.23 ± 0.01 (10) 7.27 ± 0.01 (9)* 
PCO2, mmHg 47.2 ± 1.8 (10) 50.0 ± 1.2 (9) 52.3 ± 1.8 (9) 52.2 ± 1.3 (9) 
c[HCO3-], 
mmol/L 
19.2 ± 0.9 (10) 21.5 ± 0.6 (9)* 21.2 ± 0.4 (10) 23.3 ± 0.8 (9)* 
PO2 mmHg 85.2 ± 1.8 (10) 93.9 ± 3.2 (9)* 83.3 ± 3.2 (10) 85.0 ± 3.6 (9) 
[Na+], mmol/L 147.8 ± 1.2 (9) 147.3 ± 0.7 (8) 147.1 ± 0.3 (10) 144.3 ± 0.8 (9)** 
[K+], mmol/L 4.04 ± 0.12 (10) 3.57 ± 0.15 (9)* 3.81 ± 0.18 (9) 3.38 ± 0.07 (9)* 
[Cl-], mmol/L 120.4 ± 0.9 (10) 121.0 ± 0.7 (9) 119.2 ± 0.4 (10) 115.1 ± 1.0 (9)** 
[Proteins], g/L 45.7 ± 0.8 (10) 50.2 ± 1.2 (9)** 44.4 ± 1.3 (10) 53.1 ± 2.5 (8)** 
Values are the means ± S.E (n), n= number of mice studied. Statistical significance between 
groups was assessed by unpaired Student’s t-test. * p<0.05 vs wild type mice fed same diet; 
** p<0.01 vs wild type mice fed same diet. 
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LEGENDS FOR SUPPL. FIGURES 
 
Figure S1: Von Kossa stainings of sections of kidneys from Atp6v1b1-/- and Atp6v1b1+/+ 
A, renal cortex from Atp6v1b1+/+ mouse, B renal medulla from Atp6v1b1+/+ mouse, C renal 
cortex from Atp6v1b1-/- mouse, and D renal medulla from Atp6v1b1-/- mouse. 
 
Figure S2: Western blots for ROMK on kidney samples. A. Molecular profiling of ROMK 
was assessed by Western blots in renal medullary homogenate (medulla), medullary thick 
ascending limbs (MTAL) or outer medullary collecting ducts (OMCD) from Atp6v1b1+/+ 
mice. In MTAL, anti ROMK antibody detects a broad band centered at 50kDa (curly bracket) 
and a doublet at 37 kDa (square bracket). In OMCD, anti ROMK antibody detects a major 
band that migrated above 37 kDa (arrow). A broad 50 kDa band was barely detected. In 
medulla, anti ROMK antibody detects bands that were seen in MTAL (the broad band 
centered at 50 kDa –curly bracket- and the doublet centered at 37 kDa – square bracket-) plus 
the band above 37kDa (arrow) that was seen in OMCD. Anti ROMK antibody also detects an 
additional sharp 65 kDa band (asterisk). 5 µg proteins of medullary homogenate or 
approximatively 40 tubule segments were loaded per gel lane. B. Effects of Atp6v1b1 
disruption on ROMK protein expression in medullary collecting ducts. ROMK protein 
abundance was assessed by Western blots of medullary homogenates from Atp6v1b1-/- and 
Atp6v1b1+/+. Each lane was loaded with a protein sample from a different mouse. 5 µg 
proteins were loaded per gel lane. Equal loading was confirmed by parallel Coomassie-stained 
gels. Anti ROMK antibody detects a triplet around 37 kDa in which the upper band 
corresponds to the molecular form of ROMK expressed exclusively in the collecting duct 
(arrow), whereas the two lower bands are polypeptides whose expression is restricted to the 
thick ascending limb (square bracket). Bar graph shows summary of densitometric analyses of 
the upper band (arrow). Statistical significance was assessed by unpaired Student’s t-test. ** 
P<0.01 vs. Atp6v1b1+/+ 
 
Figure S3: AQP2 expression assessed in Atp6v1b1-/- and Atp6v1b1+/+ mice by Western 
blot on renal cortex (A) or immunohistochemistry on kidney sections (B). A. Each lane 
was loaded with a protein sample from a different mouse. Equal loading was confirmed by 
parallel Coomassie-stained gels. 15 µg proteins were loaded per gel lane. Bracket and asterisk 
show the glycosylated 37 kDa and the unglycosylated 25 kDa forms of AQP2, respectively. 
Bar graph shows summary of densitometric analyses of the bracketed and asterisked bands. 
Statistical significance was assessed by unpaired Student’s t-test. * P<0.05 vs. Atp6v1b1+/+. B. 
Renal cortex from Atp6v1b1+/+ (upper panel) and Atp6v1b1-/-  (lower panel) mice. Scale bars: 
100 µm. 
 
Figure S4: Representative Coomassie blue-stained polyacrylamide gels used to control 
protein loading. Protein samples loaded on gels are the same as those used for subsequent 
Western blots. A. Whole cortex homogenates from Atp6v1b1+/+ or Atp6v1b1-/- mice. B. Whole 
medulla homogenates from Atp6v1b1+/+ or Atp6v1b1-/- mice. C. Whole cortex homogenates 
from indomethacin treated Atp6v1b1+/+ or Atp6v1b1-/- mice. D. Whole medulla homogenates 
from indomethacin treated Atp6v1b1+/+ (odd numbers) or  Atp6v1b1-/-  (even numbers) mice. 
15 µg proteins per lane were loaded on gels A and C. 5 µg proteins per lane were loaded on 
gels B and D. Bands from these gels were analyzed using densitometry to provide quantitative 
assessment of loading. Density values were normalized by dividing values by the mean value 
for the entire set of samples. Thus the mean for the entire set of samples is defined as 1. 
Normalized density values were never below 0.85 or higher than 1.15. To facilate 
comparisons between groups, density values were normalized by dividing by the mean value 
for the control group. Thus the mean for the control group is defined as 1. Bar graphs show 
summary of these densitometric analyses. Normalized band densities for mutants were 
compared with controls using an unpaired t-test. Values are means ± S.E.. In all gels, no 
difference was noted between control and mutant mice. These loading gels established that 
subsequent immunoblots (loaded identically) were uniformly loaded. 
 
 
 
 
 
